BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 29534012)

  • 61. Role of the (pseudo)halido ligand in ruthenium(II)
    Biancalana L; Zanda E; Hadiji M; Zacchini S; Pratesi A; Pampaloni G; Dyson PJ; Marchetti F
    Dalton Trans; 2021 Nov; 50(43):15760-15777. PubMed ID: 34704998
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ferrocenoyl pyridine arene ruthenium complexes with anticancer properties: synthesis, structure, electrochemistry, and cytotoxicity.
    Auzias M; Therrien B; Süss-Fink G; Stepnicka P; Ang WH; Dyson PJ
    Inorg Chem; 2008 Jan; 47(2):578-83. PubMed ID: 18085776
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Reversible pH-Responsive Behavior of Ruthenium(II) Arene Complexes with Tethered Carboxylate.
    Martínez-Peña F; Infante-Tadeo S; Habtemariam A; Pizarro AM
    Inorg Chem; 2018 May; 57(9):5657-5668. PubMed ID: 29688005
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ruthenium amino carboxylate complexes as asymmetric hydrogen transfer catalysts.
    Carmona D; Viguri F; Pilar Lamata M; Ferrer J; Bardají E; Lahoz FJ; García-Orduña P; Oro LA
    Dalton Trans; 2012 Sep; 41(34):10298-308. PubMed ID: 22825563
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparative solution equilibrium studies of antitumor ruthenium(η
    Dömötör O; Pape VFS; May NV; Szakács G; Enyedy ÉA
    Dalton Trans; 2017 Mar; 46(13):4382-4396. PubMed ID: 28287667
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Oxygenation of ruthenium carbene complexes containing naphthothiophene or naphthofuran: spectroscopic and DFT studies.
    Tsai FY; Lo JX; Hsu HT; Lin YC; Huang SL; Wang JC; Liu YH
    Chem Asian J; 2013 Nov; 8(11):2833-42. PubMed ID: 23929767
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Deactivation of ruthenium olefin metathesis catalysts through intramolecular carbene-arene bond formation.
    Vehlow K; Gessler S; Blechert S
    Angew Chem Int Ed Engl; 2007; 46(42):8082-5. PubMed ID: 17854014
    [No Abstract]   [Full Text] [Related]  

  • 68. Anticancer activity of hydrogen-bond-stabilized half-sandwich Ru(II) complexes with heterocycles.
    Mitra R; Das S; Shinde SV; Sinha S; Somasundaram K; Samuelson AG
    Chemistry; 2012 Sep; 18(39):12278-91. PubMed ID: 22903299
    [TBL] [Abstract][Full Text] [Related]  

  • 69. N-Heterocyclic Carbene Coinage Metal Complexes of the Germanium-Rich Metalloid Clusters [Ge₉R₃]
    Geitner FS; Giebel MA; Pöthig A; Fässler TF
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28753928
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Chiral eta(6)-arene/N-tosylethylenediamine-ruthenium(II) complexes: solution behavior and catalytic activity for asymmetric hydrogenation.
    Sandoval CA; Bie F; Matsuoka A; Yamaguchi Y; Naka H; Li Y; Kato K; Utsumi N; Tsutsumi K; Ohkuma T; Murata K; Noyori R
    Chem Asian J; 2010 Apr; 5(4):806-16. PubMed ID: 20235268
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Thiophenolato-bridged dinuclear arene ruthenium complexes: a new family of highly cytotoxic anticancer agents.
    Gras M; Therrien B; Süss-Fink G; Zava O; Dyson PJ
    Dalton Trans; 2010 Nov; 39(42):10305-13. PubMed ID: 20890536
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dual-targeting organometallic ruthenium(II) anticancer complexes bearing EGFR-inhibiting 4-anilinoquinazoline ligands.
    Zhang Y; Zheng W; Luo Q; Zhao Y; Zhang E; Liu S; Wang F
    Dalton Trans; 2015 Aug; 44(29):13100-11. PubMed ID: 26106875
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Catalysis of regioselective reduction of NAD+ by ruthenium(II) arene complexes under biologically relevant conditions.
    Yan YK; Melchart M; Habtemariam A; Peacock AF; Sadler PJ
    J Biol Inorg Chem; 2006 Jun; 11(4):483-8. PubMed ID: 16604356
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Chloride-assisted catalytic water oxidation.
    Chen Z; Concepcion JJ; Song N; Meyer TJ
    Chem Commun (Camb); 2014 Jul; 50(59):8053-6. PubMed ID: 24924315
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Bis-N-heterocyclic carbene (NHC) stabilized η6-arene iron(0) complexes: synthesis, structure, reactivity, and catalytic activity.
    Blom B; Tan G; Enthaler S; Inoue S; Epping JD; Driess M
    J Am Chem Soc; 2013 Dec; 135(48):18108-20. PubMed ID: 24195449
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Electronic structures of ruthenium and osmium complexes of 9,10-phenanthrenequinone.
    Biswas MK; Patra SC; Maity AN; Ke SC; Adhikary ND; Ghosh P
    Inorg Chem; 2012 Jun; 51(12):6687-99. PubMed ID: 22663598
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Synthesis and characterization of 2,6-di(quinolin-8-yl)pyridines. New ligands for bistridentate Ru(II) complexes with microsecond luminescent lifetimes.
    Jäger M; Eriksson L; Bergquist J; Johansson O
    J Org Chem; 2007 Dec; 72(26):10227-30. PubMed ID: 18001093
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Synthesis of novel anticancer ruthenium-arene pyridinylmethylene scaffolds via three-component reaction.
    Jadhav GR; Sinha S; Chhabra M; Paira P
    Bioorg Med Chem Lett; 2016 Jun; 26(11):2695-700. PubMed ID: 27090558
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Synthesis, characterization and cytotoxicity of arene-ruthenium(ii) complexes with acylpyrazolones functionalized with aromatic groups in the acyl moiety.
    Marchetti F; Pettinari R; Di Nicola C; Pettinari C; Palmucci J; Scopelliti R; Riedel T; Therrien B; Galindo A; Dyson PJ
    Dalton Trans; 2018 Jan; 47(3):868-878. PubMed ID: 29255821
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Reactions of potent antitumor complex trans-[Ru(III)Cl4(indazole)2]- with a DNA-relevant nucleobase and thioethers: insight into biological action.
    Egger A; Arion VB; Reisner E; Cebrián-Losantos B; Shova S; Trettenhahn G; Keppler BK
    Inorg Chem; 2005 Jan; 44(1):122-32. PubMed ID: 15627368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.